Search:

Login | Subscribe

Home > Companies > Minster Pharmaceuticals

Price	Market	Sector	Market Cap
9.75p (0.50p) 5.41%	AIM	Medicine and Biotech Research	£5.74m

Add to company folder | Print

Related Companies

AGY	10.00p	0.00%
APH	4.62p	0.00%
AZH	p
BBI	p
CEN	p
CBF	2.00p	0.00%
COT	91.50p	-0.54%
CRX	2.62p	0.00%
CYX	p
LAC	p
EVC	25.75p	0.00%
FUL	3.12p	0.00%
FUM	27.25p	-0.91%
GMX	1.75p	0.00%
GNI	p
GWP	29.50p	-0.84%
HML	0.42p	0.00%
MLR	p
MMG	7.25p	0.00%

Commentary

Drug development company specialising in neurological and psychiatric disorders

Recent Articles

Minster Pharmaceuticals	12/06/2008
A more palatable pill	05/10/2007
Minster Pharmaceuticals	20/07/2007
Minster keenly awaits tonabersat result	01/12/2006
Healthy demand for drug developers	30/03/2005

Recent Announcements

US Licensing Consultant	04/12/2008
Interim Results	14/11/2008
Notice of Interim Results	11/11/2008
Positive Phase II Results	22/10/2008
Symposium at AHS Meeting	30/06/2008
AHS Meeting	27/06/2008
Director/PDMR Shareholding	25/06/2008
Result of Annual General Meet	24/06/2008
AGM Statement	24/06/2008
TEMPUS study fully enrolled	16/06/2008
More

Articles from the Sector

Stroke hope at ReNeuron	28/11/2008
Futura Medical	28/11/2008
Option deal boosts ImmuPharma	25/11/2008
Digital imager targets AIM	24/11/2008
Vectura loses interim £11.7m	24/11/2008
GW trims loss	19/11/2008
Asterand	18/11/2008
EU trial cheers Plethora	07/11/2008
IS Pharma	05/11/2008
Animalcare nurturing high-margin growth	03/11/2008
More

Financial History

Financial Year End	31/03/2004	31/03/2005	31/03/2006	31/03/2007	31/03/2008
Currency	GBP	GBP	GBP	GBP	GBP
Turnover	0.00	0.00	0.00	0.00	0.00
Operating Profit	-0.04	-0.28	-1.91	-2.17	-5.63
Pretax Profit	-0.04	-0.25	-1.81	-2.12	-4.87
Earnings After Tax	-0.04	-0.25	-1.68	-1.97	-4.58
Profit Available For Dividend	0.00	0.00	0.00	0.00	0.00
Ordinary Dividends	0.00	0.00	0.00	0.00	0.00
Retained Profit	-0.04	0.00	-1.68	0.00	0.00
Shareholders Funds	0.14	15.17	13.50	28.77	24.41
Net Current Assets	0.14	2.91	1.87	0.00	0.00
Adjusted Earnings Per Share Undiluted	0.00	0.00	0.00	-6.10	-7.80
Adj Earnings Per Share	0.00	0.00	0.00	-4.20	-5.60
Dividend Per Share	0.00	0.00	0.00	0.00	0.00

Chart

Click here for interactive charting

Company Details
Address	Audley End Business Centre, The Old Forge, London Road, Wendens Ambo, Saffron Walden, CB11 4JL
Telephone	01799 506 623
Fax	01799 506 633
Executives
Chairman	John Russell (0.50% holding)
Chief Executive	Paul Sharpe (23.50% holding)
Finance Director	Robert Aubrey (0.00% holding)
Non-Exec Director	Robert Stubbs (0.20% holding)
Main Shareholders
	Care Capital: 18.3% Rho Ventures: 10.5% Fidelity International: 6.4% Gartmore: 4.8%
Advisers
Nominated Adviser	Nomura
Nominated Broker	Nomura
Solicitors	Norton Rose
Auditors	Peters Elworthy & Moore
Registrar	Capita Registrars

Commentary
Drug development company specialising in neurological and psychiatric disorders
Company Data
Code	MPM
Sedol	GB00B142W4
Shares In Issue	58.901 m
Indices	Aim
Entry on AIM	29/09/1995
Interim Results	Nov
Final Results	May
Year End	Mar
Accounts Due	Jun
Int div payment	n/a
Fin div payment	n/a
Int net div per share	nil
Fin net div per share	nil
Probable CGT relief	Yes